Yu Xie

963 total citations
46 papers, 662 citations indexed

About

Yu Xie is a scholar working on Artificial Intelligence, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yu Xie has authored 46 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Artificial Intelligence, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Yu Xie's work include Imbalanced Data Classification Techniques (15 papers), Renal cell carcinoma treatment (7 papers) and Financial Distress and Bankruptcy Prediction (5 papers). Yu Xie is often cited by papers focused on Imbalanced Data Classification Techniques (15 papers), Renal cell carcinoma treatment (7 papers) and Financial Distress and Bankruptcy Prediction (5 papers). Yu Xie collaborates with scholars based in China, United States and Saudi Arabia. Yu Xie's co-authors include Guanjun Liu, MengChu Zhou, Honghao Zhu, Changjun Jiang, Qi Kang, Chungang Yan, Abdullah Abusorrah, Deli Wu, Maozhen Li and Gang Fan and has published in prestigious journals such as PLoS ONE, Scientific Reports and Chemical Engineering Journal.

In The Last Decade

Yu Xie

44 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Xie China 15 352 111 96 93 79 46 662
Xiaoqing Zhang China 19 212 0.6× 64 0.6× 139 1.4× 53 0.6× 92 1.2× 103 967
Honghao Zhu China 11 265 0.8× 54 0.5× 124 1.3× 75 0.8× 22 0.3× 32 557
Qili Wang China 14 238 0.7× 84 0.8× 65 0.7× 61 0.7× 18 0.2× 57 815
P Zanetti Italy 11 344 1.0× 106 1.0× 71 0.7× 97 1.0× 14 0.2× 22 615
Swati Shinde India 12 356 1.0× 11 0.1× 53 0.6× 38 0.4× 65 0.8× 63 675
Shih-Wen Ke Taiwan 7 244 0.7× 12 0.1× 60 0.6× 27 0.3× 29 0.4× 11 625
Xinming Li China 15 55 0.2× 207 1.9× 36 0.4× 35 0.4× 54 0.7× 57 741
Chih‐Yang Tsai Taiwan 15 73 0.2× 43 0.4× 21 0.2× 78 0.8× 24 0.3× 27 800
Gun-Woo Kim South Korea 14 147 0.4× 19 0.2× 185 1.9× 22 0.2× 54 0.7× 83 738

Countries citing papers authored by Yu Xie

Since Specialization
Citations

This map shows the geographic impact of Yu Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Xie more than expected).

Fields of papers citing papers by Yu Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Xie. The network helps show where Yu Xie may publish in the future.

Co-authorship network of co-authors of Yu Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Xie. A scholar is included among the top collaborators of Yu Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Xie. Yu Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Yu, MengChu Zhou, Guanjun Liu, et al.. (2025). A Transactional-Behavior-Based Hierarchical Gated Network for Credit Card Fraud Detection. IEEE/CAA Journal of Automatica Sinica. 12(7). 1489–1503. 2 indexed citations
2.
Xie, Yu, et al.. (2025). GAN-Based Hybrid Sampling Method for Transaction Fraud Detection. IEEE Transactions on Knowledge and Data Engineering. 37(10). 5905–5918. 1 indexed citations
3.
Huang, Liang, et al.. (2024). Insights into immune microenvironment and therapeutic targeting in androgen-associated prostate cancer subtypes. Scientific Reports. 14(1). 18036–18036. 4 indexed citations
4.
Xie, Yu, et al.. (2024). A GAN-based Hybrid Sampling Method for Transaction Fraud Detection. 1–7. 1 indexed citations
5.
Xie, Yu, et al.. (2024). Identification of the shared gene MXD3 signatures and biological mechanism in patients with hip pain and prostate cancer. Medicine. 103(37). e39592–e39592. 1 indexed citations
6.
Xie, Yu, et al.. (2024). A Time-Aware Generative Network for Enhancing Transaction Security in Consumer Electronics. IEEE Transactions on Consumer Electronics. 71(2). 6818–6828. 1 indexed citations
7.
Xie, Yu, et al.. (2023). Upregulated HAVCR2: A Prognostic and Immune‐Related Marker in Testicular Germ Cell Tumors. Andrologia. 2023(1). 2 indexed citations
8.
Huang, Liang, Yu Xie, Shusuan Jiang, et al.. (2022). Comprehensive Characterization of Ageing-Relevant Subtypes Associated With Different Tumorigenesis and Tumor Microenvironment in Prostate Cancer. Frontiers in Molecular Biosciences. 9. 803474–803474. 1 indexed citations
9.
Xie, Yu, Shuai Zhu, Liang Yu, et al.. (2021). ADNP prompts the cisplatin-resistance of bladder cancer via TGF-β-mediated epithelial-mesenchymal transition (EMT) pathway. Journal of Cancer. 12(17). 5114–5124. 13 indexed citations
10.
Cao, Jian, et al.. (2021). Correlation Between the Evolution of Somatic Alterations During Lymphatic Metastasis and Clinical Outcome in Penile Squamous Cell Carcinoma. Frontiers in Oncology. 11. 641869–641869. 2 indexed citations
11.
Cao, Jian, Shuai Zhu, Kan Liu, et al.. (2020). Comparison of Renal Artery vs Renal Artery-Vein Clamping During Partial Nephrectomy: A System Review and Meta-Analysis. Journal of Endourology. 34(4). 523–530. 14 indexed citations
12.
Zhu, Shuai, Yong Zeng, Ying Long, et al.. (2020). ADNP Upregulation Promotes Bladder Cancer Cell Proliferation via the AKT Pathway. Frontiers in Oncology. 10. 491129–491129. 10 indexed citations
13.
Zhu, Honghao, Guanjun Liu, MengChu Zhou, et al.. (2020). Optimizing Weighted Extreme Learning Machines for imbalanced classification and application to credit card fraud detection. Neurocomputing. 407. 50–62. 119 indexed citations
14.
Xie, Yu, Lin Gu, Shun Mao, Deli Wu, & Jinhong Fan. (2019). The role of structural elements and its oxidative products on the surface of ferrous sulfide in reducing the electron-withdrawing groups of tetracycline. Chemical Engineering Journal. 378. 122195–122195. 39 indexed citations
16.
Fan, Gang, Jun Li, Mingfeng Li, et al.. (2018). Three-Dimensional Physical Model-Assisted Planning and Navigation for Laparoscopic Partial Nephrectomy in Patients with Endophytic Renal Tumors. Scientific Reports. 8(1). 582–582. 17 indexed citations
17.
Jiang, Shusuan, Sulai Liu, Yu Xie, et al.. (2015). Recurrent waist tumor subsequent to percutaneous nephrolithotomy: A case report. Oncology Letters. 10(1). 297–300.
18.
Fan, Gang, et al.. (2015). Renal metastasis from cervical carcinoma presenting as a renal cyst: A case report. Oncology Letters. 10(5). 2761–2764. 7 indexed citations
19.
Liu, Sulai, Lin Qi, Xin-xing Wan, et al.. (2014). Overexpression of Wip1 Is Associated with Biologic Behavior in Human Clear Cell Renal Cell Carcinoma. PLoS ONE. 9(10). e110218–e110218. 17 indexed citations
20.
Liu, Sulai, Qiuxia Yu, Weiqing Han, et al.. (2014). Primary gastrointestinal stromal tumor of the prostate: A case report and literature review. Oncology Letters. 7(6). 1925–1929. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026